Azurity Pharma gets US FDA approval for Danziten tablets, the first and only nilotinib with no mealtime restrictions: Woburn, Massachusetts Saturday, November 16, 2024, 17:00 Hrs ...
EMA human medicine committee recommends approval of Sanofi’s Sarclisa to treat transplant-ineligible newly diagnosed multiple myeloma: Paris Saturday, November 16, 2024, 09:00 H ...
Headstart Academy offers the largest occupational and sensory gym in Malaysia for children aged 3 to 10 with autism, attention-deficit/hyperactivity disorder (ADHD), Down syndrome, and more. In a ...